Stoke Therapeutics (STOK) Treasury Shares (2023 - 2025)

Stoke Therapeutics' Treasury Shares history runs 3 years deep, the most recent figure standing at $61000.0 for Q4 2025.

• On a quarterly basis, Treasury Shares fell 95.01% year-over-year to $61000.0 in Q4 2025; TTM through Dec 2025 was $61000.0, a 95.01% decrease from a year earlier, with the FY2025 full-year figure at $61000.0, down 95.01% from the prior year.
• Treasury Shares declined to $61000.0 in Q4 2025 per STOK's latest filing, from $1.2 million in the prior quarter.
• Across five years, Treasury Shares topped out at $1.5 million in Q4 2023 and bottomed at $61000.0 in Q4 2025.
• The 3-year median for Treasury Shares is $1.2 million (2024), against an average of $932347.0.
• Across the five-year window, Treasury Shares slipped 19.18% in 2024 and tumbled 95.01% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $1.5 million in 2023, then dropped by 19.18% to $1.2 million in 2024, then tumbled by 95.01% to $61000.0 in 2025.
• Per Business Quant, the three latest STOK Treasury Shares figures stand at $61000.0 (Q4 2025), $1.2 million (Q4 2024), and $1.5 million (Q4 2023).